Search research articles
Contact Us
Filters
Showing results (251-260 of 275) with videos related to
Page
of 28
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 3, 2019
Prophylactic cranial irradiation in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts
Paul M Putora, Markus Glatzer, José Belderbos, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 25, 2019
Consolidative thoracic radiotherapy in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts
Paul Martin Putora, Markus Glatzer, Dirk De Ruysscher, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 6, 2007
Bronchioloalveolar carcinoma and lung adenocarcinoma: the clinical importance and research relevance of the 2004 World Health Organization pathologic criteria
William D Travis, Kavita Garg, Wilbur A Franklin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 12, 2005
Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinoma
William D Travis, Kavita Garg, Wilbur A Franklin, et al.
Cancer Treatment Reviews
|
June 1, 2026
PD-(L)1 containing rechallenge strategies in patients with advanced NSCLC previously treated with immunotherapy: A systematic review and meta-analysis across resistance phenotypes
Daniele Marinelli, Fabrizio Citarella, Andrea Torchia, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 8, 2019
Erratum to "Consolidative thoracic radiotherapy in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts" [Radiother. Oncol. 135 (2019) 74-77]
Paul Martin Putora, Markus Glatzer, Dirk De Ruysscher, et al.
Journal of Translational Medicine
|
October 16, 2023
The Molecular Tumor Board of the Regina Elena National Cancer Institute: from accrual to treatment in real-world
Patrizio Giacomini, Fabio Valenti, Matteo Allegretti, et al.
Science Translational Medicine
|
September 9, 2011
Activation of ERBB2 signaling causes resistance to the EGFR-directed therapeutic antibody cetuximab
Kimio Yonesaka, Kreshnik Zejnullahu, Isamu Okamoto, et al.
The Lancet. Oncology
|
February 24, 2015
Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial
Naiyer A Rizvi, Julien Mazières, David Planchard, et al.
JTO Clinical and Research Reports
|
March 19, 2026
Definitive Radiotherapy With or Without Chemotherapy After Planned Neoadjuvant Chemoimmunotherapy in Stages II to III NSCLC: An International Multicenter Retrospective Study
Elio Adib, Amin H Nassar, Katie N Lee, et al.
Page
of 28
Search research articles
Search
Showing results (251-260 of 275) with videos related to
Sort By:
Page
of 28
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 3, 2019
Prophylactic cranial irradiation in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts
Paul M Putora, Markus Glatzer, José Belderbos, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 25, 2019
Consolidative thoracic radiotherapy in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts
Paul Martin Putora, Markus Glatzer, Dirk De Ruysscher, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 6, 2007
Bronchioloalveolar carcinoma and lung adenocarcinoma: the clinical importance and research relevance of the 2004 World Health Organization pathologic criteria
William D Travis, Kavita Garg, Wilbur A Franklin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 12, 2005
Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinoma
William D Travis, Kavita Garg, Wilbur A Franklin, et al.
Cancer Treatment Reviews
|
June 1, 2026
PD-(L)1 containing rechallenge strategies in patients with advanced NSCLC previously treated with immunotherapy: A systematic review and meta-analysis across resistance phenotypes
Daniele Marinelli, Fabrizio Citarella, Andrea Torchia, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 8, 2019
Erratum to "Consolidative thoracic radiotherapy in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts" [Radiother. Oncol. 135 (2019) 74-77]
Paul Martin Putora, Markus Glatzer, Dirk De Ruysscher, et al.
Journal of Translational Medicine
|
October 16, 2023
The Molecular Tumor Board of the Regina Elena National Cancer Institute: from accrual to treatment in real-world
Patrizio Giacomini, Fabio Valenti, Matteo Allegretti, et al.
Science Translational Medicine
|
September 9, 2011
Activation of ERBB2 signaling causes resistance to the EGFR-directed therapeutic antibody cetuximab
Kimio Yonesaka, Kreshnik Zejnullahu, Isamu Okamoto, et al.
The Lancet. Oncology
|
February 24, 2015
Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial
Naiyer A Rizvi, Julien Mazières, David Planchard, et al.
JTO Clinical and Research Reports
|
March 19, 2026
Definitive Radiotherapy With or Without Chemotherapy After Planned Neoadjuvant Chemoimmunotherapy in Stages II to III NSCLC: An International Multicenter Retrospective Study
Elio Adib, Amin H Nassar, Katie N Lee, et al.
Page
of 28